Drugs Made In America Acquisition Corp. (DMAAU) Non-Current Deffered Revenue (2025)

Drugs Made In America Acquisition (DMAAU) has 1 years of Non-Current Deffered Revenue data on file, last reported at $6.9 million in Q4 2025.

• Quarterly Non-Current Deffered Revenue changed N/A year-over-year to $6.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.9 million (changed N/A YoY) and the FY2025 annual result came in at $6.9 million, changed N/A from the prior year.
• Non-Current Deffered Revenue held at $6.9 million in Q4 2025, from $6.9 million in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $6.9 million in Q1 2025 to a low of $6.9 million in Q1 2025.